Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

887.023
-27.221-2.98%
Number of Gainers:3
Number of Losers:14
Number of Flat:- -
PE:- -
High:930.232
Open:914.556
Low:882.498
Close:914.244
Volume:327.70M
Turnover:2.64B
Market Cap:600.05B
Float Cap:495.41B

Loading ...

Sino Biopharmaceutical Stock Rises 2.9% in Hong Kong

Dow Jones
·
Sep 30

CSPC Pharmaceutical Group Stock Rallies 6.3% in Hong Kong, Outperforms Competitors

Dow Jones
·
Sep 30

AI Drug Discovery Sector Heats Up: ChinaAMC Hang Seng Biotech (03069) Rises Over 4% Intraday, ChinaAMC Innovative Drugs (03525) Gains Over 3% in Afternoon Session

Stock News
·
Sep 30

Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains

Stock News
·
Sep 30

SBP Group Shares Surge Over 4% Intraday; Citi Maintains "Buy" Rating

Deep News
·
Sep 30

Sino Biopharmaceutical Jumps Over 4% as Citi Highlights STADA Partnership to Share Licensing Drug Profits Through Production Supply

Stock News
·
Sep 30

Junshi Bio (01877) Surges Over 4% on Strategic Partnership with Meijie Medical to Explore "Multimodal Drug-Device Combination" in Cancer Treatment

Stock News
·
Sep 30

CSPC Pharma Shares Rise Nearly 6% on String of R&D Updates Spanning mRNA Cancer Vaccines and Recombinant Protein Vaccines

Stock News
·
Sep 30

CSPC Hits 5-Week High on US FDA's Nod on Herpes Zoster Vaccine Trial

Reuters
·
Sep 30

Hong Kong Stock Movers: mRNA Concept Stocks Lead Gains, CanSinoBIO (06185) Surges Over 17% as Moderna's mRNA Neoantigen Therapy Set to Debut at ESMO Congress

Stock News
·
Sep 30

Ourea Biotech HK Limited Sells 6 Million Shares of GenFleet-B (02595) at HK$27.3 Each

Stock News
·
Sep 29

Yahong Meditech (688176.SH) Plans 2026 Employee Stock Ownership Plan

Stock News
·
Sep 29

CSPC Pharmaceutical Initiates Phase IB Clinical Trial of Jmt206 Injection in China

Reuters
·
Sep 29

CSPC Pharma's JMT206 Injection Ib Phase Trial for Weight Management in Overweight or Obese Adults Officially Launches at First Site in China

Stock News
·
Sep 29

CSPC Pharma's Recombinant Shingles Vaccine SYS 6052 Gains US Clinical Trial Approval

Stock News
·
Sep 29

Cspc Pharmaceutical's Recombinant Herpes Zoster Vaccine (Sys6052) Obtains FDA Clinical Trial Approval in U.S.

Reuters
·
Sep 29

CSPC Pharmaceutical - Phase Ib Trial to Evaluate Jmt206 Injection as Monotherapy or with Semaglutide in Obesity

THOMSON REUTERS
·
Sep 29

CSPC Pharmaceutical - Phase Ib Clinical Trial of Jmt206 Injection for Weight Management in Adult Patients Initiated at First Study Centre in China

THOMSON REUTERS
·
Sep 29

Citi: Sino Biopharmaceutical and STADA Form Biosimilar Strategic Partnership, "Buy" Rating Maintained

Stock News
·
Sep 29

AH Premium Statistics for September 29

Stock News
·
Sep 29